Filter posts

BIO’s Tom DiLenge Testifies on Biotechnology Innovation Ecosystem before House E&C #SubHealth

At a hearing today held by the House Energy and Commerce Subcommittee on Health on …

Five Questions for the Senate Hearing on Prescription Drugs

On Tuesday, the Senate Committee on Health, Education, Labor, and Pensions will hold its third …

Biopharma Steps Up as Diabetes Epidemic Goes Global

This May, the World Health Organization (WHO) named its new Director-General Dr. Tedros Adhanom Chebreyesus, …

Insurers Distort the Facts on Drug Costs … Again

An effort by the Blue Cross Blue Shield Association (BCBSA) to spur a discussion on …

Dispelling Myths about GMOs and Modern Farming - A Farmer's Perspective

In the U.S., we are constantly bombarded by news around food, whether it’s the newest …

Celebrating One Health Day

Today, on the 2nd annual One Health Day, it’s important for us to recognize the …

Jim Greenwood Talks Biotech Innovation With Bloomberg Radio

While in Boston this week, BIO CEO Jim Greenwood sat down with Bloomberg Boston Bureau …

Biomedical Innovation Can Help Solve the Opioid Crisis

Opioid abuse in America touches the lives of millions. It’s estimated that more than 1,000 …

What's Driving Health Care Spending? Hint: Not Drug Costs.

With health care costs an important concern for many Americans, a common misperception is the …

ICYMI: A Bipartisan Drug Cartel?

“As false as it is implausible.” That’s how a Wall Street Journal editorial describes a …